Scott Marsh Financial’s Gilead Sciences GILD Stock Holding History

Scott Marsh Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$268K	Buy	+2,418	New	+$257K	0.1%	209

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Scott Marsh Financial's GILD Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in Gilead Sciences (GILD) in Q2 2025: 2,418 shares worth $268K. The stake represents 0.1% of the portfolio and ranks #209 among its holdings.

2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Scott Marsh Financial held 2,418 shares of Gilead Sciences worth $268K as of Q2 2025.
Gilead Sciences was a new Scott Marsh Financial position in Q2 2025.
Gilead Sciences made up 0.1% of Scott Marsh Financial's portfolio in Q2 2025, its #209 holding.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.